HMS Capital Management’s Halozyme HALO Stock Holding History

HMS Capital Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$498K	Hold	6,359	–	–	0.19%	85
2026 Q1	$411K	Buy	+6,359	New	+$448K	0.16%	90

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

HMS Capital Management's HALO Position: Q2 2026 in Review

HMS Capital Management held its Halozyme (HALO) position steady in Q2 2026 at 6,359 shares worth $498K. The position accounts for 0.19% of the portfolio, ranked #85.

HMS Capital Management first reported a position in HALO in Q1 2026 and has held it in 2 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

HMS Capital Management held 6,359 shares of Halozyme worth $498K as of Q2 2026.
HMS Capital Management left its Halozyme share count unchanged in Q2 2026.
Halozyme made up 0.19% of HMS Capital Management's portfolio in Q2 2026, its #85 holding.
HMS Capital Management first reported a position in Halozyme in Q1 2026 and has held it in 2 quarters since.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on HMS Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.